BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35921061)

  • 1. Assessment of age as different variable types for determining survival in differentiated thyroid cancer.
    Genpeng L; Yuting S; Xinyi W; Tao W; Rixiang G; Zhihui L; Jingqiang Z; Jianyong L
    Endocrine; 2022 Oct; 78(1):104-113. PubMed ID: 35921061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating the use of a two-step age-based cutoff for the UICC/AJCC TNM staging system in patients with papillary or follicular thyroid cancer.
    van Velsen EFS; Peeters RP; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Visser WE; Verburg FA
    Eur J Endocrinol; 2022 Feb; 186(3):389-397. PubMed ID: 35038308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
    Stratmann M; Sekulla C; Dralle H; Brauckhoff M
    Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?
    Wang W; Bai N; Li X
    Front Endocrinol (Lausanne); 2022; 13():939131. PubMed ID: 36339438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
    Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
    Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
    [No Abstract]   [Full Text] [Related]  

  • 9. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
    Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
    Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
    Oyer SL; Fritsch VA; Lentsch EJ
    Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
    Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
    Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
    Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
    Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
    [No Abstract]   [Full Text] [Related]  

  • 15. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
    Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
    Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
    [No Abstract]   [Full Text] [Related]  

  • 16. The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
    Wei WJ; Lu ZW; Wen D; Liao T; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    World J Surg; 2018 Jun; 42(6):1762-1771. PubMed ID: 29185020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
    Wong RM; Bresee C; Braunstein GD
    Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study.
    Wang J; Zhanghuang C; Jin L; Zhang Z; Tan X; Mi T; Liu J; Li M; Wu X; Tian X; He D
    BMC Geriatr; 2022 Sep; 22(1):736. PubMed ID: 36076163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
    Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
    Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.